Close
Jul 17, 2025 04:01PM
Jul 17, 2025 02:11PM
Jul 17, 2025 12:10PM
Jul 17, 2025 10:17AM
Jul 17, 2025 10:17AM
Jul 17, 2025 08:45AM
Jul 17, 2025 08:02AM ENHERTU plus pertuzumab gets FDA breakthrough therapy designation
Jul 17, 2025 08:01AM
Jul 17, 2025 08:01AM
Jul 17, 2025 08:01AM
Jul 17, 2025 08:00AM
Jul 17, 2025 08:00AM
Jul 17, 2025 07:05AM
Jul 17, 2025 07:02AM FDA accepts Aldeyra's reproxalap drug application for dry eye disease
Jul 17, 2025 07:01AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 16, 2025 08:00PM
Jul 16, 2025 09:31AM
Jul 16, 2025 09:21AM
Jul 16, 2025 08:45AM Silo Pharma completes dosing in PTSD drug safety study
Jul 16, 2025 08:31AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 07:31AM
Jul 16, 2025 07:15AM ICON ranks top in phase 1 clinical trials benchmarking report
Jul 16, 2025 06:30AM
Jul 15, 2025 04:41PM
Jul 15, 2025 08:31AM
Jul 15, 2025 08:27AM
Jul 15, 2025 08:01AM
Jul 15, 2025 08:01AM
Jul 15, 2025 08:00AM Kairos Pharma reports positive safety data from prostate cancer trial
Jul 15, 2025 07:45AM
Jul 15, 2025 07:30AM
Jul 15, 2025 07:00AM
Jul 15, 2025 06:00AM
Jul 14, 2025 04:01PM
Jul 14, 2025 04:01PM
Jul 14, 2025 09:32AM Merck launches phase 3 trials for monthly HIV prevention pill
Jul 14, 2025 09:31AM
Jul 14, 2025 09:16AM
Jul 14, 2025 08:31AM
Jul 14, 2025 08:03AM
Jul 14, 2025 08:03AM
Jul 14, 2025 08:01AM
Jul 14, 2025 07:30AM Iovance reports 49% response rate for Amtagvi in melanoma study
Jul 14, 2025 07:01AM

71,212 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.